Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Immuncheckpointinhibition beim Merkel-Zell-Karzinom
Translated title of the contribution
:
Immune checkpoint inhibition in Merkel cell carcinoma
P. Terheyden
*
, A. Mohr,
E. A. Langan
*
Corresponding author for this work
Clinic of Dermatology, Allergology and Venerology
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immune checkpoint inhibition in Merkel cell carcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Merkel Cell Carcinoma
100%
avelumab
31%
Drug Therapy
16%
Merkel cell polyomavirus
14%
Polyomavirus Infections
14%
Survival Rate
13%
Programmed Cell Death 1 Receptor
13%
pembrolizumab
12%
Therapeutics
11%
Blocking Antibodies
10%
Literature
9%
Skin Neoplasms
9%
Ultraviolet Rays
9%
Contraindications
8%
Tumor Burden
8%
Anti-Idiotypic Antibodies
7%
PubMed
7%
Clinical Trials
5%
Recurrence
5%